-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120

Benzinga·11/05/2026 23:08:37
Listen to the news
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $105 to $120.